213 related articles for article (PubMed ID: 11959804)
1. 2-Chloro N(6)-methyl-(N)-methanocarba-2'-deoxyadenosine-3',5'-bisphosphate is a selective high affinity P2Y(1) receptor antagonist.
Boyer JL; Adams M; Ravi RG; Jacobson KA; Harden TK
Br J Pharmacol; 2002 Apr; 135(8):2004-10. PubMed ID: 11959804
[TBL] [Abstract][Full Text] [Related]
2. Quantitation of the P2Y(1) receptor with a high affinity radiolabeled antagonist.
Waldo GL; Corbitt J; Boyer JL; Ravi G; Kim HS; Ji XD; Lacy J; Jacobson KA; Harden TK
Mol Pharmacol; 2002 Nov; 62(5):1249-57. PubMed ID: 12391289
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, biological activity, and molecular modeling of ribose-modified deoxyadenosine bisphosphate analogues as P2Y(1) receptor ligands.
Nandanan E; Jang SY; Moro S; Kim HO; Siddiqui MA; Russ P; Marquez VE; Busson R; Herdewijn P; Harden TK; Boyer JL; Jacobson KA
J Med Chem; 2000 Mar; 43(5):829-42. PubMed ID: 10715151
[TBL] [Abstract][Full Text] [Related]
4. 2-Substitution of adenine nucleotide analogues containing a bicyclo[3.1.0]hexane ring system locked in a northern conformation: enhanced potency as P2Y1 receptor antagonists.
Kim HS; Ohno M; Xu B; Kim HO; Choi Y; Ji XD; Maddileti S; Marquez VE; Harden TK; Jacobson KA
J Med Chem; 2003 Nov; 46(23):4974-87. PubMed ID: 14584948
[TBL] [Abstract][Full Text] [Related]
5. 2,2'-Pyridylisatogen tosylate antagonizes P2Y1 receptor signaling without affecting nucleotide binding.
Gao ZG; Mamedova L; Tchilibon S; Gross AS; Jacobson KA
Biochem Pharmacol; 2004 Jul; 68(2):231-7. PubMed ID: 15193995
[TBL] [Abstract][Full Text] [Related]
6. Antiaggregatory activity in human platelets of potent antagonists of the P2Y 1 receptor.
Cattaneo M; Lecchi A; Ohno M; Joshi BV; Besada P; Tchilibon S; Lombardi R; Bischofberger N; Harden TK; Jacobson KA
Biochem Pharmacol; 2004 Nov; 68(10):1995-2002. PubMed ID: 15476670
[TBL] [Abstract][Full Text] [Related]
7. Induction of novel agonist selectivity for the ADP-activated P2Y1 receptor versus the ADP-activated P2Y12 and P2Y13 receptors by conformational constraint of an ADP analog.
Chhatriwala M; Ravi RG; Patel RI; Boyer JL; Jacobson KA; Harden TK
J Pharmacol Exp Ther; 2004 Dec; 311(3):1038-43. PubMed ID: 15345752
[TBL] [Abstract][Full Text] [Related]
8. Acyclic analogues of adenosine bisphosphates as P2Y receptor antagonists: phosphate substitution leads to multiple pathways of inhibition of platelet aggregation.
Xu B; Stephens A; Kirschenheuter G; Greslin AF; Cheng X; Sennelo J; Cattaneo M; Zighetti ML; Chen A; Kim SA; Kim HS; Bischofberger N; Cook G; Jacobson KA
J Med Chem; 2002 Dec; 45(26):5694-709. PubMed ID: 12477353
[TBL] [Abstract][Full Text] [Related]
9. Identification of competitive antagonists of the P2Y1 receptor.
Boyer JL; Romero-Avila T; Schachter JB; Harden TK
Mol Pharmacol; 1996 Nov; 50(5):1323-9. PubMed ID: 8913364
[TBL] [Abstract][Full Text] [Related]
10. Methanocarba modification of uracil and adenine nucleotides: high potency of Northern ring conformation at P2Y1, P2Y2, P2Y4, and P2Y11 but not P2Y6 receptors.
Kim HS; Ravi RG; Marquez VE; Maddileti S; Wihlborg AK; Erlinge D; Malmsjö M; Boyer JL; Harden TK; Jacobson KA
J Med Chem; 2002 Jan; 45(1):208-18. PubMed ID: 11754592
[TBL] [Abstract][Full Text] [Related]
11. [32P]2-iodo-N6-methyl-(N)-methanocarba-2'-deoxyadenosine-3',5'-bisphosphate ([32P]MRS2500), a novel radioligand for quantification of native P2Y1 receptors.
Houston D; Ohno M; Nicholas RA; Jacobson KA; Harden TK
Br J Pharmacol; 2006 Mar; 147(5):459-67. PubMed ID: 16299552
[TBL] [Abstract][Full Text] [Related]
12. The C6-2B glioma cell P2Y(AC) receptor is pharmacologically and molecularly identical to the platelet P2Y(12) receptor.
Jin J; Tomlinson W; Kirk IP; Kim YB; Humphries RG; Kunapuli SP
Br J Pharmacol; 2001 Jun; 133(4):521-8. PubMed ID: 11399669
[TBL] [Abstract][Full Text] [Related]
13. Competitive and selective antagonism of P2Y1 receptors by N6-methyl 2'-deoxyadenosine 3',5'-bisphosphate.
Boyer JL; Mohanram A; Camaioni E; Jacobson KA; Harden TK
Br J Pharmacol; 1998 May; 124(1):1-3. PubMed ID: 9630335
[TBL] [Abstract][Full Text] [Related]
14. Quantification of recombinant and platelet P2Y(1) receptors utilizing a [(125)I]-labeled high-affinity antagonist 2-iodo-N(6)-methyl-(N)-methanocarba-2'-deoxyadenosine-3',5'-bisphosphate ([(125)I]MRS2500).
Ohlmann P; de Castro S; Brown GG; Gachet C; Jacobson KA; Harden TK
Pharmacol Res; 2010 Oct; 62(4):344-51. PubMed ID: 20594939
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological activity of 2-alkylated deoxyadenosine bisphosphate derivatives as P2Y(1) receptor antagonists.
Mathieu R; Baurand A; Schmitt M; Gachet C; Bourguignon JJ
Bioorg Med Chem; 2004 Apr; 12(7):1769-79. PubMed ID: 15028267
[TBL] [Abstract][Full Text] [Related]
16. Adenine nucleotide analogues locked in a Northern methanocarba conformation: enhanced stability and potency as P2Y(1) receptor agonists.
Ravi RG; Kim HS; Servos J; Zimmermann H; Lee K; Maddileti S; Boyer JL; Harden TK; Jacobson KA
J Med Chem; 2002 May; 45(10):2090-100. PubMed ID: 11985476
[TBL] [Abstract][Full Text] [Related]
17. MRS2500 [2-iodo-N6-methyl-(N)-methanocarba-2'-deoxyadenosine-3',5'-bisphosphate], a potent, selective, and stable antagonist of the platelet P2Y1 receptor with strong antithrombotic activity in mice.
Hechler B; Nonne C; Roh EJ; Cattaneo M; Cazenave JP; Lanza F; Jacobson KA; Gachet C
J Pharmacol Exp Ther; 2006 Feb; 316(2):556-63. PubMed ID: 16236815
[TBL] [Abstract][Full Text] [Related]
18. Adenine triphosphate nucleotides are antagonists at the P2Y receptor.
Kauffenstein G; Hechler B; Cazenave JP; Gachet C
J Thromb Haemost; 2004 Nov; 2(11):1980-8. PubMed ID: 15550030
[TBL] [Abstract][Full Text] [Related]
19. Novel antagonists acting at the P2Y(1) purinergic receptor: synthesis and conformational analysis using potentiometric and nuclear magnetic resonance titration techniques.
Raboisson P; Baurand A; Cazenave JP; Gachet C; Retat M; Spiess B; Bourguignon JJ
J Med Chem; 2002 Feb; 45(4):962-72. PubMed ID: 11831909
[TBL] [Abstract][Full Text] [Related]
20. Structure-activity relationships of bisphosphate nucleotide derivatives as P2Y1 receptor antagonists and partial agonists.
Nandanan E; Camaioni E; Jang SY; Kim YC; Cristalli G; Herdewijn P; Secrist JA; Tiwari KN; Mohanram A; Harden TK; Boyer JL; Jacobson KA
J Med Chem; 1999 May; 42(9):1625-38. PubMed ID: 10229631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
